Breast Cancer Research

official impact factor 5.79

Open Access Highly Access

Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics

Mollie H Wright, Anna M Calcagno, Crystal D Salcido, Marisa D Carlson, Suresh V Ambudkar and Lyuba Varticovski*

Breast Cancer Research 2008, 10:R10 doi:10.1186/bcr1855

Accesses  

  • Last 30 days: 162 accesses
  • Last year: 2406 accesses
  • All time: 15944 accesses

Cited by

BioMed Central: 12 citations

Research article   Open Access

Age determines the prognostic role of the cancer stem cell marker aldehyde dehydrogenase-1 in breast cancer

J Sven D Mieog, Esther M de Kruijf, Esther Bastiaannet, Peter JK Kuppen, Anita Sajet, Anton JM de Craen, Vincent T.H.B.M. Smit, Cornelis JH van de Velde, Gerrit-Jan Liefers BMC Cancer 2012, 12:42 (26 January 2012)

Research article   Open Access Highly Accessed

"A novel in vivo model for the study of human breast cancer metastasis using primary breast tumor-initiating cells from patient biopsies"

Carolyn G Marsden, Mary Jo Wright, Latonya Carrier, Krzysztof Moroz, Radhika Pochampally, Brian G Rowan BMC Cancer 2012, 12:10 (10 January 2012)

Research   Open Access Highly Accessed

Differentiation of breast cancer stem cells by knockdown of CD44: promising differentiation therapy

Phuc V Pham, Nhan LC Phan, Nhung T Nguyen, Nhung H Truong, Thuy T Duong, Dong V Le, Kiet D Truong, Ngoc K Phan Journal of Translational Medicine 2011, 9:209 (7 December 2011)

Research article   Open Access Highly Accessed

Generation of tumor-initiating cells by exogenous delivery of OCT4 transcription factor

Adriana S Beltran, Ashley G Rivenbark, Bryan T Richardson, Xinni Yuan, Haili Quian, John P Hunt, Eric Zimmerman, Lee M Graves, Pilar Blancafort Breast Cancer Research 2011, 13:R94 (27 September 2011)

Research   Open Access

Higher percentage of CD133+ cells is associated with poor prognosis in colon carcinoma patients with stage IIIB

Chun-Yan Li, Bao-Xiu Li, Yi Liang, Rui-Qing Peng, Ya Ding, Da-Zhi Xu, Xin Zhang, Zhi-Zhong Pan, De-Sen Wan, Yi-Xin Zeng, Xiao-Feng Zhu, Xiao-Shi Zhang Journal of Translational Medicine 2009, 7:56 (7 July 2009)

Review   Open Access Highly Accessed

Breast cancer stem cells: tools and models to rely on

Emmanuelle Charafe-Jauffret, Christophe Ginestier, Daniel Birnbaum BMC Cancer 2009, 9:202 (25 June 2009)

Viewpoint   Free

Number crunching in the cancer stem cell market

Malcolm R Alison, Shahriar Islam, Susan ML Lim Breast Cancer Research 2009, 11:302 (24 April 2009)

Review   Open Access Highly Accessed

Centrosome-associated regulators of the G2/M checkpoint as targets for cancer therapy

Yingmei Wang, Ping Ji, Jinsong Liu, Russell R Broaddus, Fengxia Xue, Wei Zhang Molecular Cancer 2009, 8:8 (13 February 2009)

Viewpoint   Free

Regulation of cancer stem cells by p53

D Joseph Jerry, Luwei Tao, Haoheng Yan Breast Cancer Research 2008, 10:304 (29 August 2008)

Review   Free Highly Accessed

Breast cancer stem cells: implications for therapy of breast cancer

Brian J Morrison, Chris W Schmidt, Sunil R Lakhani, Brent A Reynolds, J Alejandro Lopez Breast Cancer Research 2008, 10:210 (22 July 2008)

Editorial   Free Highly Accessed

Cancer stem cell heterogeneity in hereditary breast cancer

Max S Wicha Breast Cancer Research 2008, 10:105 (16 April 2008)

Research   Open Access

Molecular analysis reveals heterogeneity of mouse mammary tumors conditionally mutant for Brca1

Mollie H Wright, Ana I Robles, Jason I Herschkowitz, Melinda G Hollingshead, Miriam R Anver, Charles M Perou, Lyuba Varticovski Molecular Cancer 2008, 7:29 (7 April 2008)